Cardiovascular Efficacy and Safety of Finerenone: A Meta‐Analysis of Randomized Controlled Trials

<h3>Background</h3><p dir="ltr">Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, has emerged as a novel therapeutic option for the management of patients with diabetes, chronic kidney disease, or heart failure. We seek to summarize the evidence on the dru...

Full description

Saved in:

Bibliographic Details
Main Author:	Mushood Ahmed (19231379) (author)
Other Authors:	Areeba Ahsan (22330525) (author), Aimen Shafiq (21767660) (author), Muhammad Talha Maniya (22045973) (author), Hritvik Jain (19757091) (author), Javed Iqbal (2121922) (author), Muhammad Abdullah Naveed (22330528) (author), Raheel Ahmed (450330) (author), Jamal S. Rana (9182456) (author), Marat Fudim (12051803) (author), Gregg C. Fonarow (8135523) (author)
Published:	2025
Subjects:	Biomedical and clinical sciences Cardiovascular medicine and haematology Medical biochemistry and metabolomics Pharmacology and pharmaceutical sciences Health sciences Epidemiology cardiovascular chronic kidney disease finerenone heart failure
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Cardiovascular Efficacy and Safety of Finerenone: A Meta‐Analysis of Randomized Controlled Trials

Similar Items